Clinical and Aetiological Patterns of Paediatric Heart Failure in Nigeria: Insights Into Soluble ST2 as an Emerging Biomarker

Background Paediatric heart failure remains a major cause of morbidity and mortality in low- and middle-income countries. Soluble suppression of tumorigenicity-2 (sST2) is an emerging biomarker of myocardial stress and remodelling, but evidence in African children is limited. This study assessed the clinical and aetiological patterns of paediatric heart failure and the relationship between heart failure and plasma sST2 levels among Nigerian children. Methods This analytical cross-sectional study was conducted at the Emergency Paediatric Unit, University of Benin Teaching Hospital, Nigeria, from March to October 2024. A total of 408 children were enrolled, comprising 204 children with clinically diagnosed heart failure and 204 age- and sex-matched healthy controls. Sociodemographic, clinical, anthropometric and laboratory data were collected. Heart failure severity was assessed using the Modified Ross Classification, while plasma sST2 levels were measured and compared between groups and across aetiological categories. Results Children younger than one year accounted for 87 (42.6%) cases, while 139 (68.1%) were from lower socioeconomic groups. Most had mild (107, 52.5%) or moderate (91, 44.6%) heart failure. Pneumonia (76, 37.2%), severe malarial anaemia (65, 31.9%) and congenital heart disease (36, 17.6%) were the leading causes. Cases had significantly higher pulse and respiratory rates and lower BMI-for-age z-scores than controls (p < 0.001). Median plasma sST2 was significantly higher in cases than controls (6.26 [3.79–15.98] vs 4.05 [2.25–6.35] ng/mL; p < 0.001) and varied significantly by aetiology (p = 0.037), with highest levels in malignancy-related and pericardial heart failure. No significant sex-related differences were observed. Conclusion Paediatric heart failure was predominantly associated with pneumonia, severe malarial anaemia and congenital heart disease. Plasma sST2 was significantly elevated and varied by aetiology, suggesting potential utility as a biomarker of myocardial stress. Longitudinal studies are warranted to establish its prognostic value.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11249554/v1
Primary Topic
Heart Failure Treatment and Management
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Clinical and Aetiological Patterns of Paediatric Heart Failure in Nigeria: Insights Into Soluble ST2 as an Emerging Biomarker

Wilson E. Sadoh, Moses Temidayo Abiodun, Nandom Benjamin
Research Square
Heart Failure Treatment and Management
preprint

Clinical and Aetiological Patterns of Paediatric Heart Failure in Nigeria: Insights Into Soluble ST2 as an Emerging Biomarker

Wilson E. Sadoh, Moses Temidayo Abiodun, Nandom Benjamin
preprint en

Abstract

Background Paediatric heart failure remains a major cause of morbidity and mortality in low- and middle-income countries. Soluble suppression of tumorigenicity-2 (sST2) is an emerging biomarker of myocardial stress and remodelling, but evidence in African children is limited. This study assessed the clinical and aetiological patterns of paediatric heart failure and the relationship between heart failure and plasma sST2 levels among Nigerian children. Methods This analytical cross-sectional study was conducted at the Emergency Paediatric Unit, University of Benin Teaching Hospital, Nigeria, from March to October 2024. A total of 408 children were enrolled, comprising 204 children with clinically diagnosed heart failure and 204 age- and sex-matched healthy controls. Sociodemographic, clinical, anthropometric and laboratory data were collected. Heart failure severity was assessed using the Modified Ross Classification, while plasma sST2 levels were measured and compared between groups and across aetiological categories. Results Children younger than one year accounted for 87 (42.6%) cases, while 139 (68.1%) were from lower socioeconomic groups. Most had mild (107, 52.5%) or moderate (91, 44.6%) heart failure. Pneumonia (76, 37.2%), severe malarial anaemia (65, 31.9%) and congenital heart disease (36, 17.6%) were the leading causes. Cases had significantly higher pulse and respiratory rates and lower BMI-for-age z-scores than controls (p < 0.001). Median plasma sST2 was significantly higher in cases than controls (6.26 [3.79–15.98] vs 4.05 [2.25–6.35] ng/mL; p < 0.001) and varied significantly by aetiology (p = 0.037), with highest levels in malignancy-related and pericardial heart failure. No significant sex-related differences were observed. Conclusion Paediatric heart failure was predominantly associated with pneumonia, severe malarial anaemia and congenital heart disease. Plasma sST2 was significantly elevated and varied by aetiology, suggesting potential utility as a biomarker of myocardial stress. Longitudinal studies are warranted to establish its prognostic value.

Research Square
University of Benin (NG)
Good health and well-being
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon